Covid-19 vaccine: Date Australians will receive first jab announced

Covid-19 vaccine: Date Australians will receive first jab announced

"In South Africa, our own Health Products Regulatory Authority will review the approval applications when received from the developers and authorise their use".

Professor Shabir Madhi, a vaccine specialist at the University of the Witswatersrand.

The Australian government has confirmed it won't make the coronavirus vaccine mandatory for all its citizens.

IBM warned Thursday that it had uncovered a series of cyber attacks, potentially carried out by state actors, against companies involved in the effort to distribute vaccine doses, which must be kept cold.

The Pentagon declined comment.

It came to light, he said, after side effects in some participants turned out to be surprisingly mild.

"We now have a backlog of orders to produce", Hensler said.

Yesterday, Prime Minister Narendra Modi had said that Indian scientists are very confident about Covid-19 vaccine which would be "ready in a few weeks" asserting that India's vaccination plan would begin as soon as scientists give a go-ahead in the virtual all-party meet on Friday.

AstraZeneca is yet to complete its United States clinical trials with the current data being derived from trials in Brazil and the UK.

"What we were aware of was that we were using a different batch of a vaccine from a different manufacturer".

The preparatory planning is on for the roll-out of COVID-19 vaccination for a hassle-free and time-bound delivery of the vaccine across the Union Territory, he said.

In a letter written to healthcare colleagues, the group - which includes England's Professor Chris Whitty - also said that festive gatherings were likely to put additional pressure on the NHS.

"The fear of the vaccine will not stop the virus", he said.

The U.S. Centers for Disease Control and Prevention (CDC) did not respond to a request to comment.

For Oxford's vaccinologists, the confusion is a far cry from last week's euphoria when interim data appeared to vindicate nearly three decades of work.

"We are still hopeful, but if we receive a full submission in the next week or two, that late January, beginning of February, well ahead of the March date the government has mentioned that we will be in a position to approve one or more".

She added: "I think what you've got to do, and this is crucial as vaccine rollout happens, is that you've got to explain the rationale behind the need for vaccination".

"We're not going to be buying a vaccine, for example, Moderna, which sells for $35 (R531) a dose".

The pharmaceutical company's stock has seen its valuation depreciate by nearly £7 billion ($9.35 billion) since releasing the results after questions emerged about the two dosing regimes used in the clinical trials. Of course they should, " he said. They say the dosing pattern is also subject to discussions with regulators.